Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.
Department of Immunology, The Persian Gulf Marine Biotechnology Medicine Research Center, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Am J Surg Pathol. 2019 Mar;43(3):409-421. doi: 10.1097/PAS.0000000000001190.
Pheochromocytomas (PCCs) and abdominal paragangliomas (PGLs), collectively abbreviated PPGL, are believed to exhibit malignant potential-but only subsets of cases will display full-blown malignant properties. The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) algorithm is a proposed histologic system to detect potential for aggressive behavior, but little is known regarding the coupling to underlying molecular genetics. In this study, a total of 92 PPGLs, previously characterized for susceptibility gene status and mRNA expressional profiles, were histologically assessed using the PASS criteria. A total of 32/92 PPGLs (35%) exhibited a PASS score ≥4, including all 8 cases with malignant behavior (7 with known metastases and 1 with extensively infiltrative local recurrence). Statistical analyzes between expressional data and clinical parameters as well as individual PASS criteria yielded significant associations to Chromogranin B (CHGB), BRCA2, HIST1H3B, BUB1B, and RET to name a few, and CHGB had the strongest correlation to both PASS and metastasis/local recurrence of all analyzed genes. Evident CHGB downregulation was observed in PPGLs with high PASS and overtly malignant behavior, and was also associated with shorter disease-related survival. This finding was validated using quantitative real-time polymerase chain reaction, in which CHGB expression correlated with both PASS and metastasis/local recurrence with consistent findings obtained in the TCGA cohort. Moreover, immunohistochemical analyses of subsets of tumors showed a correlation between high PASS scores and negative or weak CHGB protein expression. Patients with PPGLs obtaining high PASS scores postoperatively, also exhibited low preoperative plasma levels of CHGB. These data collectively point out CHGB as a possible preoperative and postoperative marker for PPGLs with potential for aggressive behavior.
嗜铬细胞瘤(PCCs)和腹部副神经节瘤(PGLs)统称为 PPGL,据信具有恶性潜能-但只有部分病例会表现出完全恶性的特征。肾上腺嗜铬细胞瘤分级评分(PASS)算法是一种用于检测潜在侵袭性行为的组织学系统,但对于其与潜在分子遗传学的联系知之甚少。在这项研究中,总共 92 例 PPGL 之前已经进行了易感性基因状态和 mRNA 表达谱的特征分析,使用 PASS 标准进行了组织学评估。共有 32/92 例(35%)PPGL 的 PASS 评分≥4,包括所有 8 例具有恶性行为的病例(7 例已知转移和 1 例广泛浸润性局部复发)。对表达数据与临床参数以及个别 PASS 标准之间的统计分析显示,与嗜铬粒蛋白 B(CHGB)、BRCA2、HIST1H3B、BUB1B 和 RET 等有显著相关性,而 CHGB 与所有分析基因的 PASS 和转移/局部复发均具有最强相关性。在 PASS 评分高且具有明显恶性行为的 PPGL 中观察到明显的 CHGB 下调,并且与疾病相关的生存时间缩短有关。使用定量实时聚合酶链反应验证了这一发现,其中 CHGB 表达与 PASS 和转移/局部复发均相关,在 TCGA 队列中也获得了一致的发现。此外,对肿瘤亚组的免疫组织化学分析显示,高 PASS 评分与 CHGB 蛋白阴性或弱表达之间存在相关性。术后获得高 PASS 评分的 PPGL 患者,术前血浆 CHGB 水平也较低。这些数据共同指出 CHGB 可能是具有侵袭性行为潜力的 PPGL 的术前和术后标志物。